INTERNATIONAL PATENT: HARPOON THERAPEUTICS, INC. FILES APPLICATION FOR "INTEGRIN BETA 6 (ITGB6) TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER"

GENEVA, Dec. 24 -- HARPOON THERAPEUTICS, INC. (611 Gateway Boulevard, Suite 400South San Francisco, California 94080) filed a patent application (PCT/US2025/032813) for "INTEGRIN BETA 6 (ITGB6) TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER" on Jun 09, 2025. With publication no. WO/2025/259572, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AUSTIN, Richard J. (1169 Guerrero StreetSan Francisco, California 94110), LEMON, Bryan D. (2493 Dell AvenueMountain View, California 94043), LIN, Shuoyen Jack (2350 Evergreen D...